- Correction
- Open access
- Published:
Correction to: Downregulation of lncRNA ZNF582-AS1 due to DNA hypermethylation promotes clear cell renal cell carcinoma growth and metastasis by regulating the N(6)-methyladenosine modification of MT-RNR1
Journal of Experimental & Clinical Cancer Research volume 40, Article number: 167 (2021)
The Original Article was published on 10 March 2021
Correction to: J Exp Clin Cancer Res 40, 92 (2021)
https://doi.org/10.1186/s13046-021-01889-8
Following publication of the original article [1], the authors identified a minor error in image-typesetting in Fig. 4, specifically:
-
Figure 4j: the first mouse lung of ZNF582-AS1 OE group has been replaced with the correct image
The corrected figure is given below. The correction does not have any effect on the results or conclusions of the paper. The original article has been corrected.
ZNF582-AS1 overexpression inhibited cell migratory and invasive ability in vitro and in vivo. a and b Wound healing assay determined the migratory distances of ZNF582-AS1-overexpressed OSRC2 and Caki-1 cells and their control cells. c and d Transwell migration and e and f invasion assays determined the migratory and invasive abilities of ZNF582-AS1-overexpressed OSRC2 and Caki-1 cells and their control cells. g and h The luciferase signals in the ZNF582-AS1-overexpressed group were remarkably lower than those in the control group. i There was no significant difference between the mice weight of ZNF582-AS1-overexpressed and control group. j and k The number and size of pulmonary metastases in the ZNF582-AS1-overexpressed group were significantly reduced compared with those in the control group. l and m ZNF582-AS1 overexpression increased Ecadherin expression and decreased N-cadherin expression in pulmonary metastases
Reference
Yang W, Zhang K, Li L, Xu Y, Ma K, Xie H, et al. Downregulation of lncRNA ZNF582-AS1 due to DNA hypermethylation promotes clear cell renal cell carcinoma growth and metastasis by regulating the N(6)-methyladenosine modification of MT-RNR1. J Exp Clin Cancer Res. 2021;40(1):92. https://doi.org/10.1186/s13046-021-01889-8.
Author information
Authors and Affiliations
Corresponding authors
Additional information
The article to which this update relates has been retracted. Please see the retraction notice for more detail: https://doi.org/10.1186/s13046-023-02719-9
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
About this article
Cite this article
Yang, W., Zhang, K., Li, L. et al. Correction to: Downregulation of lncRNA ZNF582-AS1 due to DNA hypermethylation promotes clear cell renal cell carcinoma growth and metastasis by regulating the N(6)-methyladenosine modification of MT-RNR1. J Exp Clin Cancer Res 40, 167 (2021). https://doi.org/10.1186/s13046-021-01969-9
Published:
DOI: https://doi.org/10.1186/s13046-021-01969-9